Guo-pei Zhang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy and safety of lenvatinib as adjuvant therapy for hepatocellular carcinoma with vascular invasion after curative resection.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: November 23, 2025
Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway.
Journal: Cell death & disease
Published: October 25, 2025
METTL1-mediated m7G tRNA modification promotes colorectal cancer progression and liver metastasis via translational regulation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 01, 2025
Syntaxin-6 mediated autophagy confers lenvatinib resistance in hepatocellular carcinoma.
Journal: Oncogene
Published: September 29, 2024
Mechanical confinement promotes heat resistance of hepatocellular carcinoma via SP1/IL4I1/AHR axis.
Journal: Cell reports. Medicine
Published: October 11, 2022
Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: June 21, 2021
Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
Journal: Journal of cellular biochemistry
Published: September 19, 2019
Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Journal: Carcinogenesis
Published: March 28, 2019
Cripto-1 promotes tumor invasion and predicts poor outcomes in hepatocellular carcinoma.
Journal: Carcinogenesis
Published: March 28, 2019
Cathepsin C Interacts with TNF-α/p38 MAPK Signaling Pathway to Promote Proliferation and Metastasis in Hepatocellular Carcinoma.
Journal: Cancer research and treatment
Published: March 12, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026